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ABSTRACT: In this article, the use of an SPME technique is reported for the first time for direct measurement of free drug 
concentration in solid tissue. In our investigations, we considered doxorubicin (DOX) spiked in homogenized tissue matrix at transient 
and equilibrium extraction conditions, with subsequent assessment of obtained experimental results by an in-silico approach using 
mathematical models developed in COMSOL Multyphysics. In-silico studies were performed based on transported diluted species 
(tds) and reaction engineering (re) modules from COMSOL Multiphysics, using the same conditions as those used to attain 
experimental results. To determine the apparent binding affinity of DOX to the tissue matrix which contains multiple binding species, 
the experimentally determined binding affinity of DOX with human serum albumin (HSA) was considered to simplify the 
mathematical calculations. Here, the value of the binding affinity was considered for single binding site and adjusted by fitting the 
experimental results with the mathematical model. Bovine lung tissue homogenate was selected as a surrogate matrix, and a 
biocompatible C-8 commercial SPME fiber was used for extraction of DOX. In total, four mathematical models were herein 
developed to describe the mass transfer kinetics of solid coatings: in agar gel at static conditions, in PBS solution with agitated 
conditions, extraction in PBS solution in the presence of an HSA binding matrix, and static extraction in homogenized lung tissue. 
For all conditions, simulated results were in good agreement with experimental results. The developed mathematical model allows 
for measurements of free drug concentrations inside tissue matrix, and facilitates calculations of local depletion of DOX by a solid 
SPME coating. Results of the investigations indicate that local depletion of the free form of DOX, even at the kinetic stage, is 
negligible for tissue extraction, as the release of the heavily bound analyte (over 99% binding to tissue matrix) is very rapid, thus 
easily compensating for the loss of the drug to the SPME coating. This indicates that the dissociation rate constant of DOX from lung 
tissue components is very rapid; therefore, the mass transfer of drug to the fiber coating via free from is very efficient. Our results 
also indicate that thin coating SPME fibers provide a good way to measure drug distribution after dosing, as extractions via thin 
coating SPME fibers do not affect the free concentration of the drug, which is responsible for drug distribution in tissue.
One of the main aims of clinical pharmacology studies is to 
enable the most accurate measurements of drug concentrations 
in living systems, a task most likely to succeed via in vivo 
assessments of free drug concentrations at receptor sites (the 
biophase). Given that the majority of drug-receptor interactions 
take place in tissue, determining free drug concentrations at the 
intracellular space would be a more rational way to investigate 
the pharmacokinetics/pharmacodynamics (PK/PD) of a given 
drug, as compared to its measurement in blood plasma.1,2 These 
concerns are of particular importance in PK/PD studies 
involving drugs that are administered subcutaneously (SC) or 
intramuscularly (IM), as the active concentration of such drugs 
would be significantly higher in tissue in comparison to that 
present in intravenous (IV) or oral administration.. In such 
cases, the in vivo free concentration of the administered drug at 
the intracellular space would be the most appropriate indicator 
of therapeutic efficiency.3 However, given the complex nature 
of drug distribution in tissue matrix as well as the limitations of 
traditional analytical techniques available for such 
measurements, in vitro measurement of free drug 
concentrations in blood plasma is oftentimes adopted as a 
surrogate technique to study PK/PD.4–6 While a variety of 
analytical methods are available for measurement of free drug 
concentrations in tissue matrix, such as equilibrium dialysis, 
ultrafiltration, and microdialysis;7–10 few of them are capable of 
in vivo measurement. Microdialysis (MD) is the method most 
widely used to monitor free analyte concentrations in the 
extracellular space of tissue. However, the MD technique is 
burdened by major drawbacks, such as very low recovery for 
highly bound nonpolar drugs, and low temporal resolution of 
fast changing tissue components. The electrochemical 
biosensors technique, on the other hand, is highly efficient for 
measurement of rapid changing tissue components, since it 
promotes fast detection via chemical or biochemical reactions. 
However, this technique, already limited to the detection of 
electroactive analytes only, is also characterized by low 
specificity due to the presence of non-electroactive 
interferences.9,11 Due to technical difficulties, equilibrium 
dialysis and ultrafiltration are only used for in vitro analysis in 
blood plasma and other biological fluids.12,13 In this manner, 
equilibrium dialysis encounters its major experimental 
limitations in the longer equilibration times (typically 4 – 28 h), 
volume shifts and poor drug solubility. On the other side, the 
ultrafiltration technique enables nonspecific interactions with 
matrix components and equilibrium displacements, producing 
in this way a bias stemming from overestimations of the free 
concentration value.14 Given the variety of shortcomings 
associated with MD and electrochemical biosensors, a simpler 
and more robust analytical technique is thus needed to tackle 
measurements of drug concentrations in tissue. Solid-phase 
microextraction (SPME), developed in 1990,15 stands as 
particularly suitable for this application given is unique 
characteristics. In vivo SPME for analysis of tissue can be 
performed by placing a biocompatible microextraction phase 
coated onto a thin fiber into tissue matrix with minimal 
invasion. Here, unbound analytes are selectively extracted from 
the matrix by diffusion through the boundary layer. Due to the 
negligible depletive nature of the microextraction phase, SPME 
does not disturb the binding equilibrium between the analyte 
and the matrix. Further, SPME allows for extractions to be 
carried out either in the equilibrium or pre-equilibrium 
regime.16,17 These qualities of SPME render the technique as an 
ideal choice for measurements of free concentration of analytes 
from complex biological matrices, as supported by its many 
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successful applications in the biological field, both in vivo and 
ex vivo.18–20 In 2003, Lord et al. first reported the use of fiber 
SPME for in vivo monitoring of benzodiazepines in the 
systemic blood circulation of dogs.21 Since then, in vivo SPME 
applications have been widely exploited to study drug 
biomarkers and metabolomes due to the advantages associated 
with its low-invasive direct extraction capabilities, as well as its 
ability to extract analytes with wide range of polarity, an 
advantage of SPME often referred to as balanced coverage.22–25 
From a theoretical point of view, Musteata et al. explained the 
mechanism of SPME extraction of free analytes in the presence 
of a binding matrix under equilibrium conditions, where the 
unbound portion of the analyte partitions to the liquid extraction 
phase of the SPME fiber.26 In addition to the use of 
experimental techniques, mathematical modelling has been 
demonstrated as an excellent tool to determine the kinetics of 
SPME extraction in the presence of a binding matrix, as it 
allows for better predictions of results while minimizing the 
number of experiments that must be carried out during method 
development and routine analysis.17,27,28 Alam et al. first 
demonstrated the effects of a binding matrix on the extraction 
kinetics of SPME liquid coatings via development of a 2D 
model in COMSOL Multiphysics.17 Gorecki et al. and Zhou et 
al., in turn, demonstrated the extraction kinetics of solid 
coatings with the use of Langmuir’s isotherms, which assumes 
isotropy of the fiber surface.29,30 Since most of the 
biocompatible microextraction phases currently employed in 
SPME experiments for biological applications are consisted of 
a solid coating, the current work has focused on developing 
mathematical simulations of SPME kinetics in tissue matrix for 
solid coatings. To the best of our knowledge, this is the first 
time a mathematical model to measure free drug concentrations 
from tissue matrix via SPME is reported in the literature. Of 
note, the developed model, which allows for calculations of 
binding constants and free concentrations of relevant drugs 
directly from tissue, opens an exciting new area of study in 
bioanalytical chemistry.
Doxorubicin Case Study Doxorubicin (DOX) is a widely 
known chemotherapeutic agent that has been used for over 40 
years used in the treatment of many different types of cancers. 
The mode of action reveals that DOX causes potential cytotoxic 
effects by intercalating with DNA base pairs, which limits the 
proliferation of malignant tissue. However, this drug is highly 
nonselective in nature, requiring local administration to the site 
of the malignant tissue as a way to mitigate adverse side effects. 
Since the site of action of DOX is intracellular and it enters into 
the cell through passive diffusion like other small molecules, 
the drug has been commonly administered intravenously 
(IV).31,32 Pharmacokinetic studies have shown that DOX has a 
plasma half-life of 3-5 min, and a tissue half-life of 24-36 h. 
This indicates rapid uptake of DOX by tissue matrix. However, 
passive diffusion of DOX depends on the free form of DOX in 
the extracellular matrix, where it is heavily bound with multiple 
extracellular species. To the best of our knowledge, no studies 
have been reported estimating the free concentration of DOX in 
tissue matrix.33 More recently, DOX has been under preclinical 
study for treatment of metastatic lung cancer through in vivo 
lung perfusion (ILVP), where DOX concentration in lung tissue 
was determined by measurement of total drug concentrations in 
perfusate solution and serum.4 In these scenarios, it is of great 
bioanalytical interest to develop a novel technique capable of 
determining the free concentration of a drug in biological tissue 
by direct sampling, with minimum invasiveness so as to also 
enable in vivo applications. The current work presents the 
SPME extraction kinetics for solid coatings in tissue using 
numerical and experimental models. As a proof of concept, 
DOX was selected as a model drug, while bovine lung tissue 
was selected as biological matrix. The physics of the biological 
matrix were also modeled based on fundamental and biological 
parameters such as tortuosity and intracellular space of tissue 
matrix, since these factors control drug diffusion and 
distribution. Experimental results were then attained and 
compared with the developed numerical simulations. Once 
optimized, the model enabled calculations of free drug 
concentrations as well as relevant concepts for in vivo sampling, 
such as sampled area, depleted area, and spatial resolution. 
Theoretical Considerations SPME extraction takes place via 
free concentration. If the amount extracted is negligible, then 
the equilibrium concentration of the analyte in the sample 
matrix is assumed to be equivalent to the free concentration, 
which is measured according to the following equation:
                                                                             (1)[𝐴]𝑓𝑟𝑒𝑒 =
n
𝑓
Where n is the amount of analyte extracted on the fiber coating 
at equilibrium and f is the fiber constant. The value of f is then 
given by eq. (2):
                                                                             (2)𝑓 = 𝐾𝑒𝑠 ∗ 𝑉𝑓
Where,  is the volume of the extraction phase (in m3) and  𝑉𝑓 𝐾𝑒𝑠
is the partition coefficient of the analyte (dimensionless).  is 𝐾𝑒𝑠
derived from the equilibrium extraction equation Eq. (3):
                                                                        (3)𝐾𝑒𝑠 =
[𝐴]𝑒𝑞𝑓𝑖𝑏𝑒𝑟
[𝐴]𝑒𝑞𝑠𝑎𝑚𝑝𝑙𝑒
However, when solid coatings are employed in SPME, analytes 
are adsorbed on the active site of the surface area rather than 
partitioned, making the above eq. (2) inadequate for 
measurements of free concentrations under these conditions. A 
theoretical approach based on Langmuir’s theory for the 
extraction kinetics of solid coating SPME has been previously 
addressed in the literature.28,34 In brief, the amount of extract on 
the solid coating at equilibrium  (mol.m-2) is given by:𝑐𝑠𝑒𝑞
                                                                     (4)𝑐𝑠𝑒𝑞 =
γs ∗ 𝐾 ∗ [𝐴]𝑒𝑞
1 + 𝐾 ∗ [A]𝑒𝑞
Where  is the maximum free active-site concentration in the γs
fiber (mol.m-2),  is the adsorption equilibrium concentration 𝐾
(m3.mol-1), and [A]eq is the free concentration of analyte in the 
matrix at equilibrium (mol.m-3). 
The mass transfer in solid coatings is defined by Langmuir’s 
isotherm, which is defined as:
                       (5)𝑟𝑎𝑑𝑠 ― 𝑟𝑑𝑒𝑠 =  𝑘𝑎𝑑𝑠 ∗ [𝐴] ∗ (1 ― 𝜃) ― 𝑘𝑑𝑒𝑠 ∗ 𝜃
Where,  is the rate of adsorption of analyte onto the coating 𝑟𝑎𝑑𝑠
surface (mol.m-2.s-1);  is the rate of desorption (mol.m-2.s-1); 𝑟𝑑𝑒𝑠
is the adsorption rate constant (m.s-1), and is the 𝑘𝑎𝑑𝑠 𝑘𝑑𝑒𝑠 
desorption rate constant (mol.m-2.s-1). For solid coatings, the 
rates of adsorption and desorption are dependent on the fraction 
of vacant sites available on the solid surface, which is defined 
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as θ. The fraction of occupied sites on the solid surface is 
defined as:




Where  is the amount extracted on the fiber at a given time t, 𝑐𝑠
and  (mol.m-2) is the maximum active surface concentration. γs
The latter can be defined as follows:
            γs(𝑚𝑜𝑙𝑚2 ) = saturated amount extracted on the fiberactive surface area per fiber = 𝑐𝑠𝑠𝑎𝑡𝐴
Eq. (5) can be rearranged as:
                   (6)𝑟𝑎𝑑𝑠 ― 𝑟𝑑𝑒𝑠 =  𝑘𝑎𝑑𝑠 ∗ [𝐴] ∗ (1 ― 𝑐𝑠 γs) ― 𝑘𝑑𝑒𝑠 ∗ 𝑐𝑠 γs
At equilibrium, the rates of adsorption and desorption are equal. 
Therefore, eq. (5) can be expressed as:





[A]𝑒𝑞 ∗ (1 ― cs/γs)
Eq. (7) provides the partition coefficient value for an analyte in 
a given solid coating. However, if the extraction amount is 
significantly high, significant depletion of the free 
concentration of the analyte in the local area of the fiber will 
occur after the system reaches equilibrium. If we consider the 
extraction of analyte without any binding matrix present in the 
system, the free concentration will be same as the total 
concentration. Therefore, eq. (1) can be expressed as follows:






(8)                           
And equations (7) and (8) can be rewritten as:









                                                         (10)[𝐴]𝑓𝑟𝑒𝑒 =  
𝑐𝑠𝑒𝑞




Eq. (10) provides the free concentration of analyte extracted by 
a solid coating without the presence of a binding matrix. 
In the presence of a single binding matrix and univalent binding 
site, analyte  is in equilibrium with the matrix component M, A
where the binding association constant  is given by:𝐾𝐴
A + M = AM
                                                                  (11)𝐾𝐴 =
𝑘𝑓
𝑘𝑟
 =  
[𝐴𝑀]
[𝐴]𝑒𝑞 ∗ [𝑀]
Where, , and are the rate of association, rate of 𝑘𝑓 𝑘𝑟, [𝐴]𝑒𝑞 
dissociation, and concentration of  at equilibrium, 𝐴
respectively.  is the concentration of the binding matrix, and  [𝑀]
 is the concentration of analyte bound to the matrix. Eq. [𝐴𝑀]
(11) can be expressed as:
                                 (12)𝐾𝐴 =
[AM]
[A] ∗ [M] =  
[𝐴]𝑡𝑜𝑡 ― [𝐴]𝑓𝑟𝑒𝑒
[𝐴]𝑓𝑟𝑒𝑒 ∗ ([𝑀]𝑡𝑜𝑡 ― [𝐴]𝑡𝑜𝑡 + [𝐴]𝑓𝑟𝑒𝑒)
Where, is the total concentration of analyte or initial [𝐴]𝑡𝑜𝑡 
concentration,  is the free concentration of analyte, and [𝐴]𝑓𝑟𝑒𝑒
 is the total matrix concentration.[𝑀]𝑡𝑜𝑡
If the binding matrix concentration [M] ≫ [A]tot, then eq. (12) 
can be rearranged as:




A linear regression line can be obtained from eq. (13), where 
the slope gives the value of the binding association constant . 𝐾𝐴
Equation (8) describes the mass transfer kinetics of free analyte 
to the extraction phase in absence of any binding matrix. 
However, in presence of binding matrix the mass transfer 
kinetics of free analyte will be same since it depends on the 
partition coefficient  . Therefore, we can introduce the  𝐾 [𝐴]𝑓𝑟𝑒𝑒
by combining the eqs. (8) and (13):
:







                                            (14)
1
[𝐴]𝑓𝑟𝑒𝑒
=  (𝐾𝐴 ∗ [𝑀]𝑡𝑜𝑡 +1) ∗
1
[𝐴]𝑡𝑜𝑡
The binding association constant can thus be calculated by 
using eq. (14). Interestingly, the product of  from eq. 𝐾𝐴.[𝑀]𝑡𝑜𝑡
(14) is a unitless constant, which we can consider as the 
apparent binding constant . In this paper, we 𝐾𝐴𝑝𝑝 = 𝐾𝐴.[𝑀]𝑡𝑜𝑡
adopted eq. (14) for the binding study of DOX with tissue 
binding matrix. For mathematical simplification, we considered 
univalent binding site of DOX with a single binding species 
which is HSA in this case study. However, we justified the 
mathematical limitations by adjusting the experimental results 
with simulations. For experimental results we extended the 
equilibrium conditions described above by the exact equations 
to transient situations prior to equilibrium using numerical 
modeling.
EXPERIMENTAL SECTION
Materials and Supplies. Human Serum Albumin (HSA), 
doxorubicin hydrochloride (DOX), formic acid (FA), and 
ammonium acetate (LC-MS grade) were purchased from 
Sigma–Aldrich (Oakville, ON, Canada). Agar gel, methanol 
(MeOH), and water were LC-MS grade and purchased from 
Fisher Scientific (Mississauga, ON, Canada). C-8 mixed mode 
SPME fibers were kindly provided by Millipore-Sigma 
(Oakville, ON, Canada). A phosphate-buffered saline solution 
(PBS) at pH 7.4 was prepared according to the standard 
procedure described in the Supporting Information (section 1). 
Standard stock solutions were prepared in methanol at a 
concentration of 2000 µg·mL-1 and stored at -80 ºC. Bovine 
lung tissue was purchased from a local meat shop, and 
respective experiments were conducted with the approval of the 
University of Waterloo’s Office of Research Ethical Board. 
Measurement of Maximum Surface Concentration of DOX 
( ). According to eq. (9), the maximum site concentration of γs
doxorubicin on the fiber coating is attained once equilibrium is 
reached. To experimentally attain a measurement of the 
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maximum surface concentration of DOX on a C-8 mixed mode 
SPME fiber, extractions were performed at 0.5, 1, 2, 3, 4, and 5 
µg∙mL-1 initial concentrations in PBS under agitation at 1500 
rpm. The active surface area of the fiber coating was determined 
via Brunauer–Emmett–Teller (BET) analysis (S2).
Measurement of the Adsorption Equilibrium Constant (K) 
for DOX The adsorption equilibrium constant (K) for 
doxorubicin onto a C-8 mixed mode SPME substrate was 
attained by carrying out extractions under the following 
conditions: agitated equilibrium extractions from PBS were 
carried out using two different initial concentrations 
(Supporting Information; section 4). Doxorubicin was spiked at 
100 ng∙mL-1 and 50 ng∙mL-1 in PBS at pH 7.4. Extractions were 
performed at 1500 rpm with preconditioned SPME C-8 mix 
mode fibers. Fibers were preconditioned with ACN/H2O 
(80/20) for 30 mins. An extraction time profile was obtained at 
eight different time points by independent triplicates, within a 
120 min period. After each extraction time step, fibers were 
gently cleaned with Kim wipes and rinsed with 300 μL of LC-
MS grade water for 10 s to remove salts and unspecific 
attachments from the coating. Desorption was performed with 
300 μL of ACN/H2O (80/20 + 0.1% FA) for 60 min in a shaker 
at 1500 rpm. 
Static Extraction Time Profile of Doxorubicin in Agarose 
Gel: In this experiment, we evaluated the kinetic profile for 
static extraction of DOX in the absence of a binding matrix. 
Agarose powder (0.8%, w/w) was added in PBS (1X, pH 7.4) 
spiked with 100 ppb of DOX. The mixture was heated at 70⁰C 
in a water bath for 30 min. Once the agarose powder was 
completely dissolved, the solution was transferred to 2 mL glass 
vials and allowed to cool at room temperature until it attained a 
gel consistency. Then, a preconditioned SPME fiber was 
inserted into the vial containing 1.8 mL of agarose gel. Static 
extraction was performed at eight different time points for 120 
hrs. After each extraction time step, fibers were cleaned with 
Kim wipes and vortexed with 300 μL of LC-MS grade water 
for 10 s to remove matrix components from the coating. 
Desorption was performed with 300 μL of ACN/H2O (80/20 + 
0.1% FA) for 60 min in a shaker at 1500 rpm. 
Agitated Extraction Time Profile of Doxorubicin with HSA 
Binding Matrix. Human Serum Albumin (HSA) was added 
(3.6%, w/w) in PBS at pH 7.4 spiked with 100 ng∙mL-1 of DOX. 
In order to ensure the analyte sufficiently bound to the matrix, 
the solution was incubated overnight at room temperature at 
250 rpm. An extraction time profile was attained by following 
the same time levels established for PBS samples.
Measurement of Binding Association Constant KA with 
HSA. Different concentrations of HSA were prepared in PBS 
and spiked with 100 ng∙mL-1 of doxorubicin, then submitted to 
overnight incubation at 4⁰C for binding. In order to investigate 
the effect of the HSA binding matrix and subsequently attain 
free concentration measurements, equilibrium extractions were 
performed using preconditioned C-8 mixed mode SPME fibers 
for five different HSA concentrations.  
Extraction of Doxorubicin from Homogenized Lung Tissue. 
Bovine lung was cut into small pieces and homogenized using 
dry ice and a meat blender. Doxorubicin was spiked into 
homogenized lung tissue (10g of each sample) at concentration 
levels 5, 10, 15, 25, and 50 µg∙mL-1. After spiking, samples 
were gently vortexed at 500 rpm for 2 hours and then stored at 
4⁰C overnight for binding. The following day, each sample was 
equilibrated at room temperature for an hour. Extractions were 
performed from 1g of tissue sample for 25 mins under 
equilibrium conditions. After extractions, fibers were properly 
cleaned (wiped with Kimwipes) and rinsed with 300 μL of Milli 
Q water for 10 sec  to remove attached tissue matrix and other 
unspecific matrix components, then submitted to desorption in 
a vial with 300 μL of desorption solvent (80% ACN + 20% H2O 
+ 0.14% FA) for 60 minutes. 
LC-MS Characterization of Doxorubicin. DOX (MW: 543.4 
Da) was characterized using a Thermo Ultima 3000 liquid 
chromatographic system coupled to a Quantiva (Thermo 
Scientific, San Jose, CA) triple quadrupole mass spectrometer. 
The LC-MS method was carried out according to recently 
published literature.35 Briefly, liquid chromatographic 
separation was carried out using a C-18 (4.6 mm; 100mm, 5μm) 
Phenomenex column with mobile phase A (100% H2O +0.1% 
FA) and mobile phase B (100% ACN + 0.1% FA), as stated in 
the associated literature.35 The instrumental limit of 
quantification (LOQ) under these conditions was 0.1 ppb.
Mathematical Model for Extraction Time Profile on Solid 
Coating. In-silico studies were performed using COMSOL 
Multiphysics 5.3, a finite element method (FEM) based 
packages software that simulates mass transport using time-
dependent partial derivatives. For simulation of SPME 
extraction kinetics, the following modules were employed: 
transported diluted species (tds), reaction engineering (re) 
modules under Chemical Species Transport physics, and the 
laminar flow (lf) module under Fluid Flow physics. Three-
dimensional models were developed for four different 
extraction conditions: static extraction in agarose gel, agitated 
extraction in PBS, agitated extraction in the presence of an HSA 
binding matrix, and static extraction in lung tissue. The 
variables and parameters used in these models were obtained 
from experimental studies, with the exception of the value of 
the diffusion coefficient, which was adjusted based on reports 
from the literature.36,37,38 All the parameters and variables used 




In-Silico Study of Extraction Kinetics under Static 
Conditions (in Agarose Gel). Agarose gel is considered as an 
ideal matrix for static extractions without any binding matrix. 
Here, numerical simulations were based on the mass transfer 
kinetics of analytes that take place between the boundary layer 
of the SPME fiber coating and the sample matrix. The mass 
balance equation can be expressed as:
                                                   (15)𝑁𝑖 = ―∇.(𝐷∇𝑐) + 𝒖.∇𝑐 + 𝑅
Where c is the concentration of the species (mol.m-3),  denotes 𝐷
the diffusion coefficient (m2.s-1),  is the amount of any species 𝑅
produced or consumed in the system (mol.m-3.s-1), and  is the 𝒖
velocity vector (m.s-1). The flux vector  (mol.m-2.s-1) is 𝑁𝑖
associated with the net change in mass transfer at the boundary 
layer. 
In static extraction conditions for agar gel, is only controlled 𝑁𝑖 
by diffusion and the binding equilibrium.
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                                       (16) 𝑁𝑖 = ― 𝐷∇𝑐
For solid-coating adsorption kinetics, the flux vector  for 𝑁𝑖
static extraction in agarose gel can be expressed as:
                                          (17)𝑁𝑖(𝑚𝑜𝑙.𝑚 ―2.𝑠 ―1) = 𝑟𝑎𝑑𝑠 ― 𝑟𝑑𝑒𝑠
From eq. (7) and (17),
    (18)                                                                              
∂𝑐𝑠
∂𝑡 (𝑚𝑜𝑙.𝑚
―2.𝑠 ―1) = 𝑘𝑎𝑑𝑠 ∗ [𝐴] ∗ (1 ― 𝑐𝑠 γs) ― 𝑘𝑑𝑒𝑠 ∗ 𝑐𝑠 γs
Eq. (18) defines the mass transfer kinetics in static mode for 
solid coatings. The constant  was experimentally 𝑘𝑎𝑑𝑠
determined based on the assumption that  can be considered 𝑟𝑑𝑒𝑠
negligible at the start of extraction, since the amount of extract 
on the fiber is infinitesimally small. In this case, eq. (18) can be 
expressed as:
                    (19)
∂𝑐𝑠
∂𝑡 (𝑚𝑜𝑙.𝑚 ―2.𝑠 ―1) = 𝑘𝑎𝑑𝑠 ∗ [𝐴]𝑒𝑞 ∗ (1 ― 𝑐𝑠γs)
Experimentally,   can be obtained from the amount extracted 
∂𝑐
∂𝑡
on the fiber over time when the extraction rate is in the linear 
regime, which was experimentally observed to occur after 10 
mins of extraction. Prior to this time point, the amount of extract 
on the fiber was below the instrumental LOQ. Therefore, 𝑘𝑎𝑑𝑠 
from eq. (19) can be derived as follows:









Once is attained via eq. (22), the value of can be  𝑘𝑎𝑑𝑠 𝑘𝑑𝑒𝑠 
obtained from eq. (7), followed by measurement of the 
adsorption equilibrium constant K. In this work, the specific 
surface area per fiber was 4.54e-5 (m2), while the saturated 
amount of DOX extracted per fiber was determined as 5.1e-09 
(mol) (Fig S3). The calculated value of  for DOX was 1.12e-γs
04 (mol.m-2). From eq. (7), the estimated value of the adsorption 
equilibrium constant for DOX was 468 (m3.mol-1) (S4). Taking 
into account these parameters, the extraction kinetics were 
simulated and validated against experimental results. 
Simulation was performed using a 3D model designed in 
COMSOL Multiphysics, using the experimental parameters 
listed above to demonstrate the extraction kinetics in agar gel. 
The calculated results were then compared with the 
experimental extraction time profile. The simulation showed 
that the equilibrium time for static extraction was 
approximately 80 h, which is in good agreement with 
experimental results (see Figure 1). Detailed experimental 
conditions are given in the Supporting Information (section 5).
Figure 1 Comparison of in-silico and experimental extraction 
time profiles of DOX with an initial concentration of 100 
ng∙mL-1 in agarose gel.
In-Silico Study of Extraction Kinetics using Agitated 
Conditions (in PBS). Under agitation, the flux vector  can be 𝑁𝑖
expressed as:
                                  (21)                                                    𝑁𝑖 = ―∇.(𝐷∇𝑐) + 𝒖.∇𝑐 = 𝑟𝑎𝑑𝑠 ― 𝑟𝑑𝑒𝑠 
The mass transfer equation for solid coatings is the same as that 
stated in eq. (19), except that in this case, the flux changes 𝑁𝑖 
rapidly due to the convection term , which enables equilibrium 𝒖
conditions to be established at a faster rate in comparison to the 
rate of equilibrium at static conditions. In the simulation, 
convection was considered as laminar flow velocity in order to 
avoid the high degree of nonlinearity associated with the 
mathematical function. In this case, we converted the vortex 
speed used (1500 rpm) for experimental extraction into laminar 
flow velocity. 
Figure 2 Comparison of in-silico and experimental extraction 
time profiles of DOX, with initial concentration of 100 ng∙mL-
1 in PBS. 
Simulated extraction kinetics under agitated conditions 
forecasted the establishment of equilibrium at approximately 
100 min, which is in good agreement with experimental results 
(see Figure 2). 
In-Silico Study of Extraction Kinetics under Agitated 
Conditions in the Presence of an HSA Binding Matrix. In 
the presence of a binding matrix, the flux vector  is defined 𝑁𝑖
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by eq. (15). The reaction term  of eq. (15) can be derived from 𝑅
eq. (12).
          (22)𝑅 = 𝑘𝑓 ∗ ([𝐴]𝑓𝑟𝑒𝑒 ∗ [𝑀]𝑡𝑜𝑡) + 𝑘𝑟 ∗ ([𝐴]𝑡𝑜𝑡 ― [𝐴]𝑓𝑟𝑒𝑒 
Therefore, the flux for analyte in the presence of a binding 
matrix can be calculated as:
𝑁𝑖 = ―∇.(𝐷∇𝑐) + 𝒖.∇𝑐 ― 𝑘𝑓 ∗ ([𝐴]𝑓𝑟𝑒𝑒 ∗ [𝑀]𝑡𝑜𝑡) + 𝑘𝑟 ∗ ([𝐴]𝑡𝑜𝑡
                                                                   (23)― [𝐴]𝑓𝑟𝑒𝑒)
Equations used to calculate extraction time profiles in the 
presence of a binding matrix are as follows:
∂𝑐𝑠
∂𝑡 = ― 𝐷∇𝑐 + 𝒖.∇𝑐 ― 𝑘𝑓 ∗ ([𝐴]𝑓𝑟𝑒𝑒 ∗ [𝑀]𝑡𝑜𝑡) + 𝑘𝑟 ∗ ([𝐴]𝑡𝑜𝑡 ―
                                                                (24)                                                                              [𝐴]𝑓𝑟𝑒𝑒)
In order to simulate an extraction time profile in the presence of 
the HSA binding matrix, the value of the binding association 
constant (  needs to be determined experimentally by using 𝐾𝐴) 
eq. (13).  was calculated from the slope of Figure 3, yielding 𝐾𝐴
a value of 6203 (l.mol-1), which is in agreement with the value 
found in the literature.10 This calculated value was used to 
simulate an extraction time profile in the presence of a binding 
matrix, with good agreement found between simulated and 
experimental results. In this simulation, the value of the 
dissociation rate constant,  with HSA for DOX was taken to 𝑘𝑟
be 0.5 (s-1) based on a previously reported study that targeted 
similar drugs.17  In-Silico Study in Tissue Given that extraction 
in tissue matrix occurs under static conditions, the kinetics of 
extraction are calculated using the following static conditions 
formulae. The mass balance equation for tissue can be 
expressed as:
                                                                (25)𝑁𝑖 = ―∇.(𝐷∇𝑐) +𝑅
Figure 3 Ratio of bound and free analyte concentrations as a 
function of HSA concentration. Initial concentration of DOX 
was 100 ng∙mL-1.
Therefore, the flux  can be expressed as:𝑁𝑖
                                                                                 
∂𝑐𝑠
∂𝑡 = ― 𝐷∇𝑐 ― 𝑘𝑓 ∗ ([𝐴]𝑓𝑟𝑒𝑒 ∗ [𝑀]𝑡𝑜𝑡) + 𝑘𝑟 ∗ ([𝐴]𝑡𝑜𝑡 ― [𝐴]𝑓𝑟𝑒𝑒)
(26)
In the case of tissue matrix, an assumption based on eq. (14) is 
made to consider the apparent binding association constant 
. The product of  is a unitless factor, 𝐾𝐴𝑝𝑝 = 𝐾𝐴.[𝑀]𝑡𝑜𝑡 𝐾𝐴.[𝑀]𝑡𝑜𝑡
and a constant for a given matrix. Here,  defines the total [𝑀]𝑡𝑜𝑡
concentration of binding matrices. Since DOX has binding 
affinity to DNA, serum albumin, cell membrane, and other 
binding agents presents in the tissue matrix, calculating the true 
concentration of the binding matrix in tissue is therefore 
impractical due to the complex nature of the binding 
mechanism.39,40 Therefore, we consider as an apparent 𝐾𝐴𝑝𝑝 
binding constant, which can be predicted in a well-defined 
mathematical model by changing the total matrix concentration 
. As the value of  for DOX in the HSA matrix has been [𝑀]𝑡𝑜𝑡 𝐾𝐴
experimentally attained,  can thus be estimated, yielding a 𝐾𝐴𝑝𝑝
value of 1252 from a mathematical model fitted with the 
experimentally attained extraction time profile. This hypothesis 
was validated theoretically via simulations, where extraction 
kinetics were performed with different  and  values for 𝐾𝐴 [𝑀]𝑡𝑜𝑡
the same . Simulated results showed similar extraction 𝐾𝐴𝑝𝑝
kinetics behavior which is not affected by the individual value 
of  and  for a given  value (see Figure 4). This 𝐾𝐴 [𝑀]𝑡𝑜𝑡 𝐾𝐴𝑝𝑝
observation provided by mathematical simulation simplified 
the complexities associated with experimental conditions, 
particularly when it becomes cumbersome to differentiate the 
binding association constant for each different binding matrix 
present in the sample.
 
Figure 4 In-silico investigation of the apparent binding 
constant . The extraction kinetic profiles behaved similarly 𝐾𝐴𝑝𝑝
despite using different matrix concentrations [M] and binding 
association constants  for the same . Initial 𝐾𝐴 𝐾𝐴𝑝𝑝
concentration  was 25 µg∙g-1. [𝐴]𝑡𝑜𝑡
Figure 5 Comparison of in-silico and experimental extraction 
time profiles of doxorubicin (25 µg∙g-1) in homogenized bovine 
lung tissue.
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Experimental results from tissue showed that approximately 7 
ng of DOX are extracted when an initial concentration of 25 
µg∙g-1 is spiked into tissue. As Figure 5 shows, extraction 
reached equilibrium after 25 min (equilibration time was herein 
defined as the time needed for 95% of the total equilibrium 
concentration to be extracted onto the coating), which is 
reasonable given the high binding affinity of DOX for lung 
tissue components. Simulated results were well-fitted with 
experimental results despite the fact that experimental errors are 
higher at lower time points due to the proximity of the 
experimentally extracted amount to experimental LOQ values. 
For all other studied initial concentrations in tissue matrix, the 
amount of extract at equilibrium fitted linearly to in-silico 
extracted amounts, while the analytical concentration of the 
sample was observed in the range studied. In-silico results were 
in agreement with the attained experimental results.35 Finally, 
the free concentration of DOX from lung tissue was estimated 
from eq. (14), yielding a value of 1.25e-05 (mol.m-3) for 25 µg∙g-
1. These results indicate that DOX is heavily bound to the tissue 
matrix, at an estimated binding percentage of 99.97%. The 
experimentally attained value was very close to the value 
generated by numerical simulations. 
Negligible Depletion of Free Concentration and Spatial 
Resolution To determine the free concentration of analyte in 
the presence of binding matrix components, negligible 
depletion of the free concentration surrounding the SPME fiber 
is imperative. Figure 6 (a) describes how the free concentration 
DOX depletes over the time around the SPME fiber at static 
extraction in agar gel. The X axis represents the distance from 
the SPME fiber in millimeter while the Y axis is the 
concentration of DOX in the sample matrix in mol.m-3. At the 
beginning of extraction time profile, the depletion of 
concentration in the proximity of the fiber is higher (the green 
line graph at 1h). The total length of the X axis is considered as 
the dimension of the sample matrix which is the diameter of the 
glass vial (10 mm) used in the experiment. From that figure, we 
can assume that the boundary layer thickness is approximately 
8 mm after 1h of extraction. However, close to the equilibrium 
(the blue line graph at 82 h) there is no gradient of concentration 
around the fiber. On the other hand, extraction from tissue 
matrix apparently exhibited negligible depletion of the free 
concentration at equilibrium conditions, as seen in Figure 6 
(b).Therefore, although the C-8 mixed mode SPME fiber 
enabled significant depletion of the free concentration of DOX 
at equilibrium, estimated at approximately 60 percent of the 
initial concentration, extraction from tissue matrix apparently 
exhibited negligible depletion of the free concentration at 
equilibrium conditions. Such a phenomenon enabled by the 
rapid release of DOX from the matrix-bound complex, 
indicating that the binding matrix and the SPME extraction 
phase compete for DOX. In fact, the binding matrix works as a 
buffer to maintain the free form of DOX surrounding the fiber 
while it is being extracted onto the extraction phase. It should 
be noted as well that the free concentration of DOX will likely 
not change in the matrix system unless the dissociation rate 
constants are slow.17 This also indicates that successive 𝑘𝑟
extractions from the same place within the sample matrix 
should not matter particularly when the percentage of the matrix 
bound complex is significantly high, as the matrix replenishes 
the free concentration rapidly. Figure 6 (c) evidences the 
spatial resolution of the SPME sampling by showing the 
depleted DOX concentration volume surrounding the fiber at 
equilibrium. This indicates that placing multiple SPME fibers 
in a small region of sample matrix should not interfere in the 
extraction kinetics. Therefore, experimental results should 
incur less bias relative to the matrix. 
CONCLUSIONS 
This article theoretically studies the extraction dynamics of 
molecules from bovine lung tissue using solid-phase 
microextraction, further presenting experimental validation of 
the COMSOL simulation models using, as a proof of concept, 
a well-known chemotherapeutic drug, doxorubicin (DOX) as a 
model compound. In this context, a novel technique was 
introduced for measurement of free drug concentration in 
bovine tissue homogenate by using biocompatible C-8 mixed 
mode SPME fiber. Also, theoretical studies were discussed and 
defined to interpret several crucial concepts on mass transfer 
kinetics that take place in tissue matrix. To validate the 
established mathematical models, a novel SPME technique to 
determine free and bound concentrations from tissue by either 
in vivo or ex vivo sampling was theoretically developed and 
experimentally established, using DOX. The attained 
experimental results were explained and cross-validated by 
mathematical COMSOL simulations, which described in detail 
the mass transfer kinetics of DOX in lung tissue matrix. 
Moreover, derived from this primary work, several relevant 
concepts concerning tissue sampling, such as apparent binding 
constant, spatial resolution, and local depletion, were developed 
and discussed. Of note, the attained results help to shed light on 
the principle of SPME tissue extraction, including in vivo 
extraction scenarios. As part of this investigation, the unbound 
free concentration of analyte is shown to remain constant when 
a thin coating SPME fiber is used, as the amount of analyte that 
is transferred to the coating is replaced from the reservoir of 
analyte bound to the tissue matrix.
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Figure 6 (a) COMSOL simulation shows the change of DOX 
concentration in agarose gel across a line drawn through the 
center of the SPME fiber at different extraction times. The X 
axis shows the distance from the fiber, and the Y axis represents 
concentration. The initial concentration was 0.1 µg∙mL-1 (b) 
The change in the free concentration of DOX in tissue at 
equilibrium, indicating that the gradient in concentration is 
negligible. The initial concentration was 25 µg∙g-1. (c) The 
spatial resolution of the concentration gradient of DOX across 
a 2D line cut through the SPME fiber.
In addition, the presented work represents the first attempt to 
measure free drug concentrations in tissue matrix with the 
assistance of mathematical models. The key attributes of the 
herein presented numerical models include estimation of the 
apparent binding constant KApp of DOX in tissue matrix, 
demonstration of negligible depletion, and spatial resolution for 
multiple ex vivo or in vivo samplings. Here, KApp is defined as a 
unitless constant that describes the binding properties of an 
analyte in a specific sample matrix; in this work, the KApp for 
DOX in bovine lung tissue was estimated as 1252. The value of 
KApp is difficult to estimate experimentally since the total 
concentration of binding species [M] is unknown in a given 
tissue matrix. This limitation is herein addressed by taking 
advantage of the mathematical models established in this work. 
Although this study was performed using homogenized tissue, 
future research efforts may include estimation of in vivo free 
concentrations in the extracellular space of tissue matrix. The 
developed simulation approach thus substantiates that SPME 
can be used as a valuable tool for accurate measurements of free 
drug concentrations in tissue matrix. Of note, we could have 
selected BSA as a binding matrix to estimate the binding 
association constant KA instead of HSA. However, given that 
the ultimate goal of this ongoing research concerns future 
implementation of this technique for in vivo determinations in 
human lung tissue, HSA was herein selected as binding matrix. 
Finally, the output of this article is not only limited to DOX or 
lung tissue, but also paves the way for quantitation of free and 
conjugated forms of other drugs in any complex biological 
matrix. In fact, this study will allow for exploration of 
completely new horizons in biomedical sciences, such as in 
vivo monitoring of drug pharmacodynamics in tissue, without 
the need of correlative investigations using surrounding 
biofluids or biopsies.
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